STD AAPPS FOA Frequently Asked Questions
1. The CDC Project Description/Approach/Program Strategy/Assurance_Partner Services/Outreach Services and Linkage to Care section of the FOA states Partner Services activities conducted by DIS do not include early latent syphilis unless they are HIV co-infected. Should awardees provide partner services to a 16 year old female patient with a 1:512 but no signs/symptoms of syphilis, who is not pregnant, and HIV negative?
Awardees should use local epidemiology and policies to follow up with those most likely to transmit disease in the community. (July 9, 2013)
2. What is the rationale behind conducting partner services for HIV co-infected gonorrhea cases? Does CDC have any recommendations on how to prioritize gonorrhea cases when the volume of cases is so high?
Partners of HIV co-infected gonorrhea cases should be prioritized for Disease Intervention Specialist (DIS) partner services because they represent a group at high risk for HIV infection, and provision of partner services should facilitate diagnosis and linkage to care.
Other gonorrhea cases that should be prioritized for partner services are cases with possible gonorrhea treatment failure or suspected or probable cephalosporin-resistant N. gonorrhoeae infection, using the criteria in the Cephalosporin-Resistant N. gonorrhoeae Public Health Response Plan (http://www.cdc.gov/std/treatment/Ceph-R-ResponsePlanJuly30-2012.pdf).
STD programs are encouraged to conduct automated matching of STD and HIV cases to identify co-infected individuals and target these cases for partner services, and to improve data available for additional epidemiologic studies.
CDC staff can assist awardees with prioritization. (July 9, 2013)
3. Are jurisdictions with large syphilis morbidity required to conduct HIV/gonorrhea co-infected partner services?
Yes, jurisdictions with large syphilis morbidity are required to do HIV/gonorrhea co-infected partner services. (July 9, 2013)
4. Under the Assurance/Screening and Treatment of Individuals per CDC Guidance section of the FOA, a required activity is, “increase the proportion of patients with gonorrhea that are correctly treated according to current CDC guidelines in areas of high gonorrhea morbidity.” Please define “correctly.” Does this include only the recommended treatment? Does this include published alternative regimens? Are alternative regimens sufficient even if we cannot document the test of cure?
Correctly treated includes all recommended and alternative therapeutic regimens published in the STD Treatment Guidelines. No other regimens are acceptable. (August 7, 2013)